Panacea Biotec Ltd (PANACEABIO) - Financial and Strategic SWOT Analysis Review

Panacea Biotec Ltd (PANACEABIO) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82245FSA
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Panacea Biotec Ltd (PANACEABIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; and combinative vaccines, including Easyfive-TT (DTwP-HepB-Hib), Novohib (haemophilus typeb conjugate vaccine IP) and Polprotec (inactivated poliomyelitis vaccine). Its pharmaceutical formulations span the therapeutic areas of oncology, nephrology, pain management, diabetes management, and organ transplantation. The company also offers contract research and manufacturing services. Panacea operates research and development centers and manufacturing facilities. It has subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Ltd Key Recent Developments

Mar 09,2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA

Oct 17,2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Panacea Biotec Ltd-Key Facts 6

Panacea Biotec Ltd-Key Employees 7

Panacea Biotec Ltd-Key Employee Biographies 8

Panacea Biotec Ltd-Major Products and Services 9

Panacea Biotec Ltd-History 14

Panacea Biotec Ltd-Company Statement 17

Panacea Biotec Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 19

Section 2-Company Analysis 20

Company Overview 20

Panacea Biotec Ltd-Business Description 21

Business Segment: Formulations 21

Overview 21

Performance 21

Business Segment: Research and Development 21

Performance 21

Business Segment: Vaccines 22

Overview 22

Performance 22

Geographical Segment: Domestic 22

Performance 22

Geographical Segment: Overseas 22

Performance 22

R&D Overview 22

Panacea Biotec Ltd-SWOT Analysis 23

SWOT Analysis-Overview 23

Panacea Biotec Ltd-Strengths 23

Panacea Biotec Ltd-Weaknesses 24

Panacea Biotec Ltd-Opportunities 25

Panacea Biotec Ltd-Threats 26

Panacea Biotec Ltd-Key Competitors 27

Section 3-Company Financial Ratios 28

Financial Ratios-Capital Market Ratios 28

Financial Ratios-Annual Ratios 29

Performance Chart 32

Financial Performance 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Panacea Biotec Ltd, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Mar 09, 2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA 37

Oct 17, 2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control 38

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

Panacea Biotec Ltd, Performance Chart (2014-2018) 32

Panacea Biotec Ltd, Ratio Charts 33

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35

List of Tables

Panacea Biotec Ltd, Key Facts 6

Panacea Biotec Ltd, Key Employees 7

Panacea Biotec Ltd, Key Employee Biographies 8

Panacea Biotec Ltd, Major Products and Services 9

Panacea Biotec Ltd, History 14

Panacea Biotec Ltd, Other Locations 18

Panacea Biotec Ltd, Subsidiaries 18

Panacea Biotec Ltd, Joint Venture 19

Panacea Biotec Ltd, Key Competitors 27

Panacea Biotec Ltd, Ratios based on current share price 28

Panacea Biotec Ltd, Annual Ratios 29

Panacea Biotec Ltd, Annual Ratios (Cont...1) 30

Panacea Biotec Ltd, Annual Ratios (Cont...2) 31

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

Panacea Biotec Ltd, Recent Deals Summary 36

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Indus Biotech Pvt Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Elder Pharmaceuticals Ltd

Dalas Biotech

Cadila Healthcare Ltd

Panacea Biotec Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8913
Site License
USD 250 INR 17825
Corporate User License
USD 375 INR 26738

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com